sunvozertinib   Click here for help

GtoPdb Ligand ID: 11672

Synonyms: DZD-9008 | DZD9008 | Example 52 [WO2019149164A1]
Approved drug
sunvozertinib is an approved drug (China (2023))
Compound class: Synthetic organic
Comment: We obtained the chemical structure for sunvozertinib from WHO Proposed list 125, in which it is described as a tyrosine kinase inhibitor with proposed antineoplastic action. This mapped to PubChem CID 139377809. Sunvozertinib is one of the compounds that are claimed in Dizal (Jiangsu) Pharmaceutical's patent WO2019149164A1 as ERBB/BTK inhibitors [2]. Subsequent information revealed sunvozertinib (DZD9008) as an oral, irreversible inhibitor with selectivity for mutant EGFR [3].
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 9
Hydrogen bond donors 4
Rotatable bonds 11
Topological polar surface area 114.88
Molecular weight 583.25
XLogP 4.47
No. Lipinski's rules broken 0
Click here for help
Canonical SMILES C=CC(=O)Nc1cc(Nc2nccc(n2)Nc2cc(Cl)c(cc2C(O)(C)C)F)c(cc1N1CC[C@H](C1)N(C)C)OC
Isomeric SMILES Clc1c(cc(c(Nc2nc(ncc2)Nc2c(cc(c(c2)NC(=O)C=C)N2C[C@@H](CC2)N(C)C)OC)c1)C(C)(C)O)F
InChI InChI=1S/C29H35ClFN7O3/c1-7-27(39)34-22-14-23(25(41-6)15-24(22)38-11-9-17(16-38)37(4)5)35-28-32-10-8-26(36-28)33-21-13-19(30)20(31)12-18(21)29(2,3)40/h7-8,10,12-15,17,40H,1,9,11,16H2,2-6H3,(H,34,39)(H2,32,33,35,36)/t17-/m1/s1
1. Dhillon S. (2023)
Sunvozertinib: First Approval.
Drugs, 83 (17): 1629-1634. [PMID:37962831]
2. Li Z, Zou H, Zhu W, Shen C, Wang R, Liu W, Chen X, Tsui H, Yang Z, Zhang X. (2019)
Erbb/btk inhibitors.
Patent number: WO2019149164A1. Assignee: Dizal (Jiangsu) Pharmaceutical Co., Ltd. Priority date: 31/01/2018. Publication date: 08/09/2019.
3. Wang M, Yang JC, Mitchell PL, Fang J, Camidge DR, Nian W, Chiu CH, Zhou J, Zhao Y, Su WC et al.. (2022)
Sunvozertinib, a Selective EGFR Inhibitor for Previously Treated Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations.
Cancer Discov, 12 (7): 1676-1689. [PMID:35404393]